Efficacy of ulinastatin in acute severe carbon monoxide poisoning with myocardial injury requiring respiratory support in early stage
-
摘要: 目的:探讨乌司他丁(UTI)用于早期需给予呼吸机辅助呼吸的急性重度一氧化碳中毒(ASCOP)合并心肌损伤患者的治疗效果。方法:采用前瞻性研究方法,将收治的96例ASCOP患者,按区组随机分组原则分为UTI组和对照组,对照组患者常规给予吸氧、间断呼吸机纯氧吸入、脱水降颅压、清除自由基、营养心脑细胞等基础治疗,UTI组在对照组治疗的基础上给予乌司他丁静脉滴注(10万U静脉滴注,q8h),两组患者均连续治疗7 d;收集两组患者入院时昏迷时间及治疗后昏迷时间、ICU住院时间、血压、吸烟等资料;计算格拉斯哥评分(GCS评分);收集治疗前后的血常规并计算中性粒细胞与淋巴细胞比值即NLR、IL-6、肌钙蛋白I(cTnI)、肌酸磷酸肌酶同工酶(CK-MB)、缺血修饰白蛋白(IMA);行心电图检查并计算心电图异常发生率。比较两组治疗前后心功能变化(左心室射血分数、左心室舒张末期内径、左心室短轴缩短率)。采用t检验及χ2检验进行统计学分析。结果:治疗前,两组血清WBC计数、NLR值及IL-6比较,差异无统计学意义(P>0.05);乌司他丁治疗1周,UTI组炎性指标水平明显低于对照组,差异有统计学意义(P<0.05);治疗前,两组血清心肌缺血标记物即IMA及CK-MB水平比较,差异无统计学意义(P>0.05);乌司他丁治疗1周,UTI组水平明显低于对照组,差异有统计学意义(P<0.05);治疗前,两组患者心电图异常发生率均为68.75%,治疗后UTI组心电图异常发生率明显降低(P<0.05)。治疗后乌司他丁治疗组的昏迷时间及ICU住院时间明显缩短(P<0.05)。治疗后,两组心功能均得到改善,UTI组改善较明显,差异有统计学意义(P<0.05)。结论:ASCOP合并心肌损伤时尤其是不能行高压氧治疗时,在间断纯氧吸入的基础上,应用UTI,可以拮抗炎症反应,改善心肌组织的损伤,对ASCOP后心肌损伤具有一定的保护作用。Abstract: Objective: To explore the therapeutic effect of ulinastatin(UTI) in patients with acute severe carbon monoxide poisoning(ASCOP) complicated with myocardial injury requiring ventilator assisted respiration.Methods: Prospective research method was adopted, the 96 patients with ASCOP were randomly divided into UTI group and control group.Patients in the control group were routinely given basic treatments such as oxygen inhalation, intermittent ventilator pure oxygen inhalation, cranial pressure reduction by dehydration, free radical scavenging and cardiac brain cell nutrition.The UTI group was given ulinastatin intravenous infusion(100, 000 U intravenous infusion,q8 h) on the basis of the control group.Patients in both groups received continuous treatment for 7 days.The coma time at admission and after treatment, ICU stay, blood pressure, smoking and other data were collected.Calculate the Glasgow score(GCS score).Blood routine was collected before and after treatment, and the ratio of neutrophils to lymphocytes, namely NLRwas calculated. IL-6, troponin I(cTnI), creatine phosphocreatine isoenzyme(CK-MB), and ischemia modified albumin(IMA) were collected, as well. ECG examination was performed and the incidence of ECG abnormalities was calculated. Changes in cardiac function(left ventricular ejection fraction, left ventricular end-diastolic diameter, left ventricular short-axis shortening) were compared between the two groups before and after treatment. T-test and chi-square test were used for statistical analysis.Results: Before treatment, there was no significant difference in WBC count, NLR value and IL-6 between the two groups(P> 0.05).After ulinastatin treatment for one week, the levels of inflammatory indexes in the UTI group were significantly lower than those in the control group(P< 0.05).Before treatment, there was no significant difference in the levels of serum myocardial ischemia markers, IMA and CK-MB, between the two groups(P>0.05); after 1 week of ulinastatin treatment, the level of UTI group was significantly lower than that of control group(P<0.05).Before treatment, the incidence of abnormal ECG in both groups was 68.75%, and after treatment, the incidence of abnormal ECG in UTI group was significantly reduced(P<0.05). After treatment, the duration of coma and ICU stay in ulinastatin group was significantly shortened(P<0.05). After treatment, cardiac function was improved in both groups, but was significantly improved in UTI group(P<0.05).Conclusion: When ASCOP complicated with myocardial injury, especially when hyperbaric oxygen therapy cannot be performed, on the basis of intermittent pure oxygen inhalation, the application of UTI can antagonize the inflammatory response, improve myocardial tissue damage, and have a certain protective effect on myocardial injury after ASCOP.
-
Key words:
- ulinastatin /
- poisoning /
- carbon monoxide /
- neutrophil/lymphocyte ratio /
- myocardial injury /
- ischemia-modified albumin
-
[1] Bhakthavatsala Reddy C,Cyriac C,Desle HB.Role of“Ischemia Modified Albumin”(IMA)in acute coronary syndromes[J].Indian Heart J,2014,66(6):656-662.
[2] 韩永燕,王岩,赵国强,等.中性粒细胞与淋巴细胞比值和急性一氧化碳中毒心肌损伤的关系[J].中华劳动卫生职业病杂志,2018,36(5):362-364.
[3] Liu S,Xu J,Gao Y,et al.Multi-organ protection of ulinastatin in traumatic cardiac arrest model[J].World J Emerg Surg,2018,13:51.
[4] 肖世辉.急危重症一氧化碳中毒患者早期呼吸机替代高压氧治疗的分析[J].中国当代医药,2017,24(9):40-42.
[5] 中华人民共和国卫生部.职业性急性化学物中毒性心脏病诊断标准GBZ 74-2009[S].北京:中国标准出版社,2009.
[6] 李雅琴,亢宏山,叶艳巧,等.呼吸机治疗急性重度一氧化碳中毒疗效观察[J].河北医科大学学报,2010,31(4):391-393.
[7] 李耀宗,刘思达,胡潇,等.急性一氧化碳中毒对心脏损伤的研究进展[J].临床急诊杂志,2020,21(11):913-918.
[8] Deniz T,Kandis H,Eroglu O,et al.Carbon monoxide poisoning cases presenting with non-specific symptoms[J].Toxicol Ind Health,2017,33(1):53-60.
[9] 吕信鹏,邓颖.一氧化碳中毒迟发性脑病的相关研究进展[J].医学综述,2017,23(1):100-103.
[10] Garg J,Krishnamoorthy P,Palaniswamy C,et al.Cardiovascular abnormalities in carbon monoxide poisoning[J].Am J Ther,2018,25(3):e339-348.
[11] 张建国,张惠茹,史学颖,等.急性一氧化碳中毒患者血清酶活力的动态变化[J].中华劳动卫生职业病杂志,2003,21(1):51-53.
[12] Thygesen K,Aipert JS,Jaffe AS,et al.Fourth universal definition of myocardial infarction(2018)[J].Circulation,2018,138(20):e618-e651.
[13] 刘欢,李艳,许淑文,等,血清CKMB、MYO、血清cTnI和血浆NT-ProBNP联合检测诊断急性心肌梗死的临床价值[J].海南医学,2015,26(23):3496-3499.
[14] 王璞,李伟,杨俊礼,等.乌司他丁对急性重度一氧化碳中毒患者心肌损害的效果[J].中华劳动卫生职业病杂志,2018,36(2):154-156.
[15] 张林,陈玥,张宝红.血小板-淋巴细胞比率、中性粒细胞-淋巴细胞比率及红细胞分布宽度在冠心病严重程度中的诊断价值[J].临床心血管病杂志,2020,36(9):824-827.
[16] Khwannimit B,Bhurayanontachai R,Vattanavanit V.Comparison of the accuracy of three early warning scores with SOFA score for predicting mortality in adult sepsis and septic shock patients admitted to intensive care unit[J].Heart Lung,2019,48(3):240-244.
[17] Shin IW,Jang IS,Lee SM,et al.Myocardial protective effect by uli nastatin via an anti-inflammatory response after regional ischemia / reperfusion injury in an in vivo rat heart model[J].Korean J Anesthesiol,2011,61(6):499-505.
计量
- 文章访问数: 192
- PDF下载数: 86
- 施引文献: 0